LQR63300 |
Gold User, Member, Platinum User, TeleChart
|
Registered User |
|
|
|
|
Unsure |
|
Friday, February 24, 2006 |
Monday, August 3, 2009 9:54:58 AM |
2 [0.00% of all post / 0.00 posts per day] |
|
I would recommend,XOMA, for both short term and long term. I have been following XOMA for more than two years, since DNA recieved the FDA clearance for Raptiva, and since then the clearance for Lucentis which appears to be a 1 billion dollar antibody. XOMA collects royalties on these two drugs and since the success of their technology has been proven more than once, they have established major relationships with other big pharma to continue on. I think this stock is extremely under valued specially since they have collected more than 10million in rolyalties for the DNA drugs, and already an additional 10 million to be added to next quarters revenue. This I see a very good short term play and long term play if that is your cup of TEA.
|
I think the chart is looking very nice. ORCH went under my radar for quite some time. Your opinion is appreciated.
|
|